189 results
8-K
EX-1.1
TVTX
Travere Therapeutics, Inc.
8 Nov 24
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:13pm
or any of its subsidiaries of any class of capital stock. (j) Independent Accountants. Ernst & Young LLP, which has expressed its opinion with respect … of the Registration Statement, the Time of Sale Prospectus and the Prospectus, is (i) an independent registered public accounting firm as required
424B5
placknh8
8 Nov 24
Prospectus supplement for primary offering
4:11pm
424B5
sqv0p
7 Nov 24
Prospectus supplement for primary offering
4:01pm
424B5
lvqmcaftgl1er0crvesp
31 Oct 24
Prospectus supplement for primary offering
8:41am
S-3ASR
EX-4.12
eih9mo0
1 Aug 24
Automatic shelf registration
5:24pm
S-3ASR
EX-23.1
18tf ftjkngq9mf2ow
1 Aug 24
Automatic shelf registration
5:24pm
S-3ASR
EX-23.2
xubm5zj o58izov75g
1 Aug 24
Automatic shelf registration
5:24pm
S-3ASR
7xcq8x2t
1 Aug 24
Automatic shelf registration
5:24pm
S-8
EX-23.2
6ee14i
14 Jun 24
Registration of securities for employees
4:05pm
S-8
EX-23.3
civwlxeu3p7th2bp1b
14 Jun 24
Registration of securities for employees
4:05pm
8-K
otpg8
13 May 24
Departure of Directors or Certain Officers
4:05pm
DEFA14A
o8hq lx6k7owsp
27 Mar 24
Additional proxy soliciting materials
4:33pm